Page last updated: 2024-11-03

praziquantel and Nephrosis, Lipoid

praziquantel has been researched along with Nephrosis, Lipoid in 1 studies

azinox: Russian drug

Nephrosis, Lipoid: A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Turner, I1
Ibels, LS1
Alexander, JH1
Harrison, A1
Moir, D1

Other Studies

1 other study available for praziquantel and Nephrosis, Lipoid

ArticleYear
Minimal change glomerulonephritis associated with Schistosoma hematobium infection--resolution with praziquantel treatment.
    Australian and New Zealand journal of medicine, 1987, Volume: 17, Issue:6

    Topics: Adult; Albuminuria; Animals; Biopsy; Hematuria; Humans; Kidney; Male; Nephrosis, Lipoid; Praziquante

1987